[DNLI] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -3.82%
YoY- -20.66%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 641 145,149 0 0 0 0 0 -
PBT -23,678 -22,887 -21,844 -22,134 -21,320 -19,354 -30,611 -15.74%
Tax 0 -807 0 0 0 90 0 -
NP -23,678 -22,887 -21,844 -22,134 -21,320 -19,354 -30,611 -15.74%
Tax Rate - - - - - - - -
Total Cost 24,319 168,036 21,844 22,134 21,320 19,354 30,611 -14.23%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -3,693.92 -15.77 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -0.26 -0.74 -0.27 -0.32 -2.36 -2.15 -4.51 -85.10%
EPS Diluted -0.26 -0.74 -0.27 -0.32 -2.36 -2.15 -4.51 -85.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.